Neuromyelitis Optica Spectrum Disorder: Updates on Diagnosis and Treatment
Three agents were recently FDA approved for NMOSD in adults who are AQP4 antibody positive: eculizumab, inebilizumab-cdon, and satralizumab-mwge
Three agents were recently FDA approved for NMOSD in adults who are AQP4 antibody positive: eculizumab, inebilizumab-cdon, and satralizumab-mwge